Obstructive Lung Diseases |

Impact of Cardiovascular Comorbidities on Treatment Outcome in COPD Patients FREE TO VIEW

A. P. Kansal*, MD; Parul Mrigpuri, MBBS; Amitesh Gupta, MBBS; Vishal Chopra, MD; Komaldeep Kaur, MBBS; Sudesh Kumari, MD
Author and Funding Information

Govt. Medical College, Patiala, India

Chest. 2012;142(4_MeetingAbstracts):725A. doi:10.1378/chest.1389001
Text Size: A A A
Published online



PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM

PURPOSE: To study the pattern of co-existing cardiovascular morbidities in COPD patients presenting to Department of Chest and Tuberculosis, Government Medical College, Patiala, India

METHODS: The study was done on 300 patients of COPD presenting to department of chest and tuberculosis government medical college Patiala, India. The diagnosis of COPD was based on history, clinical examination and post bronchodilator spirometric measurements. The COPD patients were then investigated for coexistence of cardiovascular manifestations including systemic hypertension, pulmonary artery hypertension, coronary artery disease and right ventricular failure by means of ECG and Echocardiography.

RESULTS: 3.7% patients had findings suggestive of involvement of cardiovascular system on examination but 53% of the patients had abnormal ECG findings suggestive of CVS involvement. Out of 159(53%) patients with ECG suggestive of involvement of cardiovascular system, 0 (0%) belonged to stage 1, 30 (19.9%) to stage 2, 67 (42.1%) to stage 3 and 48 (30.2%) were in stage 4 of COPD. On echocardiographic evaluation, 114 (38%) patients had echocardiographic evidence of ventricular hypertrophy. 107 (35.6%) patients had atrial hypertrophy, 63 (21%) cases had evidence of pulmonary artery hypertension.

CONCLUSIONS: COPD should be treated as a systemic disease and management involves co-ordination with various specialties including Pulmonologists, cardiologists, neurologist, critical care specialists, and physiotherapists.

CLINICAL IMPLICATIONS: COPD is emerging as one of the important public health challenges and a major cause of chronic morbidity and mortality throughout the world. Cardiovascular involvements like systemic hypertension, pulmonary artery hypertension, coronary artery disease, cor-pulmonale, arrhythmias are the prominent co-morbidities found among COPD patients.

DISCLOSURE: The following authors have nothing to disclose: A.p. Kansal, Parul Mrigpuri, Amitesh Gupta, Vishal Chopra, Komaldeep Kaur, Sudesh Kumari

No Product/Research Disclosure Information

Govt. Medical College, Patiala, India




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543